BOEHRINGER INGELHEIM USA | Boehringer Ingelheim | Missouri | state | 2015 | $13,879 | | tax credit/rebate |
Boehringer Ingelheim USA Corporation | Boehringer Ingelheim | Connecticut | state | 2012 | $98,000 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2014 | $506,133 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica Inc. | Eli Lilly | Iowa | state | 2015 | $516,584 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2001 | $1,119,362 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2011 | $740,939 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $3,239,000 | | grant |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2012 | $1,944,528 | | tax credit/rebate |
Boehringer Ingelheim Vetmedica, Inc. | Eli Lilly | Iowa | state | 2010 | $5,275,484 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2014 | $273,219 | | tax credit/rebate |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2011 | $55,000 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2012 | $195,000 | | grant |
Boehringer Ingleheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2009 | $138,096 | | tax credit/rebate |
Boehringer Ingleheim Pharmaceuticals, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2010 | $99,643 | | tax credit/rebate |
Boehringer Laboratories, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2008 | $32,435 | | tax credit/rebate |
Boehringer Laboratories, Inc. | Boehringer Ingelheim | Pennsylvania | state | 2010 | $6,436 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2012 | $16,858 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2013 | $17,655 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2015 | $9,465 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2016 | $14,977 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2010 | $13,009 | | tax credit/rebate |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2003 | $343,428 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2004 | $355,511 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2005 | $327,383 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2006 | $592,901 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2007 | $478,724 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | Massachusetts | state | 2006 | undisclosed | | tax credit/rebate |
Bristol Myers Squibb Company | Bristol-Myers Squibb | Arizona | state | 2022 | $3,000,000 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2009 | $361,233 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2009 | $343,915 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2010 | $414,326 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2008 | $358,648 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2011 | $410,028 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2012 | $393,682 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | Massachusetts | state | 2006 | $67,000,000 | | MEGADEAL (Archived) |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2013 | $426,654 | | tax credit/rebate; property tax abatement |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2014 | $452,064 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2015 | $416,585 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2016 | $414,936 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2017 | $412,873 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2019 | $390,739 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2020 | $390,921 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2021 | $390,427 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $2,779,200 | | tax credit/rebate |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | Florida | state | 2014 | $3,500,000 | | grant |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2007 | $101,500 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2009 | $137,500 | | training reimbursement |
Bristol-Myers Squibb Co., Inc. | Bristol-Myers Squibb | New York | Local | 2018 | $406,056 | | tax credit/rebate |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | New Jersey | state | 1997 | $4,200,000 | | grant |
Bristol-Myers Squibb Company, Inc. | Bristol-Myers Squibb | New York | state | 2002 | $275,000 | | enterprise zone |
Bristol-myers Uspng | Bristol-Myers Squibb | Michigan | state | 1989 | undisclosed | | property tax abatement |
Buasch & Lomb | Bausch Health | Florida | local | 2005 | $4,795 | | grant |
C3I | Merck | New Hampshire | state | 2014 | $9,576 | | training reimbursement |
C3I | Merck | New Hampshire | state | 2015 | $5,908 | | training reimbursement |
C3i Incorporated | Merck | Pennsylvania | state | | $458,000 | | tax credit/rebate |
C3i Incorporated | Merck | Pennsylvania | state | | $400,000 | | grant |
C3I, INC | Merck | California | local | 2012 | undisclosed | | tax credit/rebate |
C3I, Inc. | Merck | New Hampshire | state | 2012 | $9,105 | | training reimbursement |
C3i, Inc. | Merck | Pennsylvania | state | | $500,000 | | grant |
C3i, Inc. | Merck | Pennsylvania | state | | $512,000 | | tax credit/rebate |
C3i, Inc. | Merck | Pennsylvania | state | 2014 | $512,000 | | tax credit/rebate |
C3I,Incorporated | Merck | New York | local | 2002 | $50,592 | | grant |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2012 | $24,402 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2014 | $98,490 | | tax credit/rebate |
Cambrex | Cambrex | Maryland | local | 2007 | undisclosed | | grant |
Cambrex Charles City, Inc | Cambrex | Iowa | state | 2012 | $537,648 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2006 | $165,000 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2015 | $1,330,020 | | tax credit/rebate |
Cambrex Charles City, Inc. | Cambrex | Iowa | State | 2017 | $300,898 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $494,275 | | grant/loan hybrid program |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2020 | $458,408 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2017 | $502,233 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2014 | $740,512 | | training reimbursement |
Cambrex Charles City, Inc. | Cambrex | Iowa | state | 2013 | $318,203 | | training reimbursement |
Cambrex Corporation | Cambrex | Maryland | state | 2004 | $19,690 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2011 | $300,000 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | | tax credit/rebate |
Cangene bioPharma, Inc. | Emergent BioSolutions | Maryland | local | 2009 | undisclosed | | enterprise zone |
CASCADIAN THERAPEUTICS INC | Seattle Genetics Inc. | Washington | state | 2015 | $19,669 | | tax credit/rebate |
CASCADIAN THERAPEUTICS INC | Seattle Genetics Inc. | Washington | state | 2016 | $19,669 | | tax credit/rebate |
CASCADIAN THERAPEUTICS, INC. | Seattle Genetics Inc. | Washington | state | 2017 | $157,351 | | tax credit/rebate |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $345,800 | | tax credit/rebate |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $81,096 | | Tax credit/rebate |
Celgene Corporation | Bristol-Myers Squibb | New Jersey | state | 2004 | $6,086,250 | | grant |
CENTOCOR BIOLOGICS, LLC SERIES 2005 | Johnson & Johnson | Missouri | state | 2006 | $386,661 | | tax credit/rebate |
Centocor Research & Development Inc. | Johnson & Johnson | Pennsylvania | state | 2008 | $4,806,417 | | tax credit/rebate |
Centocor Research & Development, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $402,833 | | tax credit/rebate |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $1,000,000 | | training reimbursement |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $3,000,000 | | tax credit/rebate |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $2,000,000 | | grant |
Cephalon | Teva Pharmaceutical Industries | Utah | state | 2009 | $1,683,200 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $1,749,000 | | tax credit/rebate |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | | $4,000,000 | | grant |
Cephalon, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2011 | $740,231 | | tax credit/rebate |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $699,000 | | tax credit/rebate |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | | $5,000,000 | loan or bond financing |
Cherokee Pharmaceuticals, LLC | Merck | Pennsylvania | state | | $1,200,000 | | grant |
Chimerix, Inc. | Chimerix | North Carolina | state | 2013 | $1,816 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2014 | $11,365 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2016 | $184,324 | | tax credit/rebate |